Flerie
Venture capital · Stockholm, Sweden · Europe
Flerie is a Stockholm-based life science investment firm that invests off its own balance sheet in biotech and pharmaceutical companies. It manages over SEK 2,500 million in assets across product development and commercial growth segments and supports portfolio companies through active board work, expertise and its network.
Invests inHealthcare & Biotech
In its own wordsbiotechpharmaceuticalsdrug developmentcell and gene therapyvaccineslife sciences
Your fit with Flerie
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsFlerie lists 21 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Growth, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (90%), Climate & Energy (5%) and AI & Machine Learning (5%). 67% of its companies are based in Sweden. It invests most often alongside 3B Future Health Fund, British Business Bank and Brunnur Ventures.
Counts come from funding rounds that name Flerie, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Flerie's whole history. Rounds on record name 1 company; its own site lists 21. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 100% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 53th | 21 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 63th | 5% of companies confirmed by a round |
| Sector focus | 96th | 90% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| 3B Future Health Fund | 2 |
| British Business Bank | 1 |
| Brunnur Ventures | 1 |
| Cambridge Innovation Capital | 1 |
| Eir Ventures | 1 |
| First Spark Ventures | 1 |
| Industrifonden | 1 |
| Khosla Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers21100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 90% | 15% |
| Climate & Energy | 5% | 1% |
| AI & Machine Learning | 5% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with 3B Future Health Fund
Compare Flerie head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Flerie| Date | Company | Stage |
|---|---|---|
| 16 Oct 2026 | Series C+ |
Round details for Flerie
Amounts, full round histories and every co-investor in Flerie's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
21 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Amarna Therapeutics develops and advances a pipeline of gene therapies for various diseases | Healthcare & Biotech | Portfolio page | ||
| AnaCardio is developing novel drugs to treat heart failure | Healthcare & Biotech | Portfolio page | ||
| Atrogi develops first-in-class oral compounds for muscle wasting | Healthcare & Biotech | Portfolio page | ||
| Bohus Biotech develops and produces hyaluronic acid products for various therapeutic areas, including aesthetics, ophthalmics, and orthopedics. | Healthcare & Biotech | Portfolio page | ||
| Bonsai Biotherapeutics is a biopharmaceutical company developing next-generation therapies for autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Buzzard Pharmaceuticals is developing a next-generation IL-1 inhibitor in cancer indications | Healthcare & Biotech | Portfolio page | ||
| Chromafora is an innovative Swedish cleantech company that uses unique treatment methods and patented technologies to remove PFAS and heavy metals from polluted water, and to extract valuable metals for recycling. | Climate & EnergyAI & Machine Learning | Portfolio page | ||
| EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing oral drugs for chronic respiratory diseases, focusing on the high unmet need of COPD patients. | Healthcare & Biotech | Portfolio page | ||
| Frontier Biosolutions invests in and provides services for the development of biopharmaceutical drugs | Healthcare & Biotech | Portfolio page | ||
| Geneos Therapeutics develops DNA-based personalized immunotherapies for cancer | Healthcare & Biotech | Portfolio page | ||
| Lipum develops an anti-inflammatory drug with first-in-class potential | Healthcare & Biotech | Portfolio page | ||
| Mendus explores the power of the immune system to improve long-term survival of cancer patients, while preserving health and quality of life. | Healthcare & Biotech | Portfolio page | ||
| Microbiotica is translating clinic-led microbiome science into medicines. | Healthcare & Biotech | Oct 2026Series C+ | Page + round | |
| Nanologica is a partner to the pharmaceutical industry, providing products and services for the development, production, and purification of pharmaceutical substances. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Prokarium develops microbial immunotherapies for the treatment of solid tumors | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Symcel develops and provides rapid sterility testing and microbial detection systems | Healthcare & Biotech | Portfolio page | ||
| Vitara Biomedical is a medical technology company reinventing the standard of care for extremely premature newborns. | Healthcare & Biotech | Portfolio page | ||
| Xintela develops groundbreaking stem cell therapies and targeted cancer therapies for diseases that lack effective treatment | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- flerie.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 16 Oct 2026
- Companies checked
- 21
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Flerie's profile as data
Pull Flerie's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/flerie.com
# also
GET /v1/firms/flerie.com/portfolio
GET /v1/firms/flerie.com/coinvestors
GET /v1/firms/flerie.com/news